DECISION OF THE EEA JOINT COMMITTEE No 14/2024

of 2 February 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1554]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Regulation (EU) 2023/2482 of 13 November 2023 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards the substance bis(2-ethylhexyl) phthalate (DEHP) in medical devices ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 12zc (Regulation (EC) No 1907/2006 of the European Parliament and of the Council) of Chapter XV of Annex II to the EEA Agreement:

‘—

32023 R 2482 : Commission Regulation (EU) 2023/2482 of 13 November 2023 ( OJ L, 2023/2482, 14.11.2023 ).’

Article 2

The text of Regulation (EU) 2023/2482 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 3 February 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 2 February 2024.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L, 2023/2482, 14.11.2023 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/1554/oj

ISSN 1977-0677 (electronic edition)